检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

678 A phase 2 study of evorpacept (ALX148) in combination with pembrolizumab in patients with advanced head and neck squamous cell carcinoma (HNSCC); ASPEN-03

Kevin Harrington,Ezra Cohen,Bhumsuk Keam,Jean-Pascal Machiels,Sjoukje Oosting,Brett Hughes,Jong Chul Park,Tim Welliver,Christine Ju,Feng Jin,Alison Forgie,Jaume Pons,Sophia Randolph,Athanasios Tsiatis

Regular and Young Investigator Award Abstracts（2022）

引用 0|浏览10
暂无评分
关键词
pembrolizumab,evorpacept,squamous cell carcinoma,advanced head
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要